News & Press Release
- 2025年08月25日 For the Press Nobelpharma Co., Ltd. Has entered into an Exclusive Distribution Agreement with A.R.C. Laser GmbH for Otorhinolaryngo Laser Systems in Japan
- 2025年07月29日 Product Information Launch of Melatobel Tablet 1 mg/2 mg for Pediatric, A Melatonin Receptor Agonist that Improves the Sleep Onset
- 2025年07月28日 Product Information Notification of Approval Acquisition (China) for Melatonin Granules “Manlejing®”, a Japanese product named “Melatobel® Granules for Pediatric Use 0.2%”
Contribute to Society
by Providing
Critical
but Neglected
Pharmaceuticals
and Medical Devices
-
-
Managing Director & CEO - We have been driving our business forward, giving priority to the patient benefit since our founding.
-
-
-
- We have been working to develop critical but neglected drugs and medical devices, taking pride in the corporate philosophy that is unique to Nobelpharma.
-
-
-
- We have unique business strategies that distinguish us from many other pharmaceutical companies.
-
-
-
- We are dedicated to critical but neglected drugs and medical devices to fulfill the needs of the society.
-
-
-
- "Nobel" of our company name comes from the famous Alfred Nobel, the founder of the Nobel Prize.
-
-
-
Development - We develop curative drugs and medical devices for diseases that large pharmaceutical companies overlook because of the small number of patients or for other reason.
-
-
-
- The archive provides our financial statements and annual business reports.
-
-
- Promotional Video
-
Promotional Video
-
- Corporate Video
-
Corporate Video
Our Stories "Lamp"
"I walk in the darkness of the night with a lamp in my hand. I must not worry about the darkness but trust the lamp as my guide."
In the darkness, a lamp makes you assured. We will pursue the right path to go, trusting the lamp in our hearts.